Harvey Sihota, founder and chief executive of Neurokinex, said: “There is no doubt that spinal stimulation technology will take spinal cord injury rehab to the next level, bringing even more meaningful functional improvements that offer people greater independence.”.
And Spinal Research chairwoman Tara Stewart said the study suggests “it’s now time to stop talking about spinal cord injury as being incurable”.
Dave Marver, chief executive of Onward Medical, said the study “provides critical insights to the spinal cord injury community, demonstrating that improvements resulting from ARC-EX Therapy extend for at least one year, with no observed plateau”.
The technology delivers electrical pulses through the skin to stimulate the spinal cord which means that signals weakened or interrupted by a spinal cord injury can drive movement.
The mother of two is one of 10 spinal cord injury patients who took part in a study assessing new stimulation technology.
